Reversing EZH2‐Mediated Epigenetic Silence with Photodynamic Polymeric Nanoparticles for Synergistically Enhanced Antitumor Immunotherapy

Author:

Cao Lei12345,Tang Dongsheng6,Yu Zhen13,Shen Yue13,Wang Yang13,Li Yue‐Qin37,Chen Juan13,Liu Zhao‐Qian234,Yin Ji‐Ye2345ORCID,Xiao Haihua6,Li Xiang‐Ping13

Affiliation:

1. Department of Pharmacy Xiangya Hospital Central South University Changsha Hunan 410008 P. R. China

2. Department of Clinical Pharmacology Xiangya Hospital Central South University Changsha 410008 P. R. China

3. National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha 410008 P. R. China

4. Institute of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics Central South University Changsha 410008 P. R. China

5. Engineering Research Center of Applied Technology of Pharmacogenomics Ministry of Education 110 Xiangya Road Changsha 410008 P. R. China

6. Beijing National Laboratory for Molecular Sciences State Key Laboratory of Polymer Physics and Polymer Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing 100190 P. R. China

7. Institute of Integrative Medicine Department of Integrated Chinese and Western Medicine Xiangya Hospital Central South University Changsha 410008 P. R. China

Abstract

AbstractEndogenous T cell activation relies on recognizing tumor‐specific antigens. However, tumor cells often alter phenotypes to evade immune surveillance, resulting in immune escape and drug resistance. Photodynamic therapy (PDT) activates anti‐tumor immune responses by generating reactive oxygen species, which induce endoplasmic reticulum stress and immunogenic cell death. The clinical application of PDT is limited by immunosuppressive tumor microenvironment. Notably, enhancer of zeste homolog 2 (EZH2) regulates expression of immune‐related genes in tumor and immune cells through H3K27 methylation. Consequently, targeting EZH2‐mediated epigenetic silence provides an effective strategy to enhance the anti‐tumor immune effect of PDT. In this study, a nano‐delivery system (NP2) is designed to demonstrate PDT and epigenetic reprogramming effects. NP2 can reverse epigenetic silence, enhance MHC‐I expression, and induce release of CXCL9‐10 via EZH2i. Meanwhile, NP2 has a significant effect on PDT, inducing endoplasmic reticulum stress that resulted in immunogenic cell death and subsequent activation of the immune cascade. In a mouse model of in situ breast cancer, the combination of PDT activation and epigenetic reprogramming through EZH2i showed synergistic effects on remolding, and triggering a robust anti‐tumor immune response in vivo. This study provides a novel idea for improving the immunosuppressive environment in clinical individualized immunotherapy.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3